Mr Kenneth Kang | Principal Scientist and Head of Purification Team of BioProcess Sciences
Eli Lilly and Co

Mr Kenneth Kang, Principal Scientist and Head of Purification Team of BioProcess Sciences, Eli Lilly and Co

Dr. Kenneth Kang is a Principal Scientist and the Head of Protein Purification Team in Bioprocess Sciences Department for Eli Lilly New York City, and has over 14 years of experience on protein purification process development in biotechnology /biopharmaceutical industry. His role at Eli Lilly, includes managing the early-stage protein purification process development, identifying, evaluating and implementing new and advanced technologies in the field of protein purification with a focus on streamlining mAb downstream processes.  Prior to Lilly, Dr. Kang was an investigator and a project leader for Progenics, where he managed a team to support both vaccines and mAb therapeutics pipelines. Prior to joining Progenics, Dr. Kang held a senior scientist position at Wyeth (now Pfizer), he was part of the purification PD group and delivered many development projects.  His 20 peer-reviewed publications and patents/patent applications cover a range of scientific pursuits, including protein purification, vaccines and monoclonal antibody therapeutics.

back to speakers
Error processing SSI file